Similarly 2024 guidelines published by ESC for atrial fibrillation management do not mention GLP-1 RAs as part of management [51]
Ongoing Care Regular follow-ups with biomarker tracking, clinical assessments, and protocol optimization to maximize your longevity outcomes
Mhurchu and co-workers recently reported that chitosan treatment did not result in a clinically significant loss of body weight compared with placebo in a 24-week randomised, double-blind, placebo-controlled trial in overweight and obese adults (250 participants with a body mass index of 35.5 +/- 5.1) (66)
Potential Side Effects Common side effects are nausea, vomiting, diarrhea, and constipation
Most people find the injections pretty painless with the right technique
Need urgent medical intervention: If you have severe obesity with acute complications requiring immediate medical management, hospital-based weight loss surgery evaluation, or intensive medical supervision, telehealth GLP-1 platforms are not a substitute for urgent in-person care